The food and beverage group, which includes brands such as Evian, Volvic and Alpro, recorded Q2 like-for- like sales up +4.2%. As a result basis, first half sales hit €13.9bn up +3.5% on a like-for-like basis.
Antoine de Saint-Affrique, CEO, said: “We are closing a solid first half, demonstrating once again the relevance of our health-focused portfolio and the strength of our multi-engine growth model.”
The company has continued to strengthen its position in health-focused beverages through acquisitions, including its recent purchase of Australia-based Made Group.
In the second quarter Danone said that EDP showed “continued momentum” across Europe, Middle East and Africa (EMEA), with functional dairy and Alpro in strong demand.
Specialised Nutrition delivered an improved performance supported by a catch-up in the Middle East and a progressive recovery in Europe throughout Q2. Meanwhile, the Waters division delivered a “solid start” to the summer season, led by Volvic.
In the Americas EDP reported a solid performance, driven by functional yogurts. North America saw continued strong growth in High Protein with Specialised Nutrition, both Medical Nutrition, driven by Neocate and infant milk formula across Latin America delivering double-digit growth.
The APAC region also saw “solid growth” in specialised Nutrition, with EDP in Japan seeing continued strong activation driving demand for Oikos and Activia.
Waters reflected a mix of strong, competitive growth with Aqua in Indonesia and soft category for Mizone in China.
Antoine de Saint-Affrique, added: “Demand for our winning platforms remained strong, including High-protein products and Medical Nutrition across all regions, and Skyr, Kefir and Plant-based in Europe.”
He said that the company continued to enhance its portfolio in attractive health-focused categories through M&A, including the signing of agreements to acquire Huel and Made Group.
“While some areas still require further progress and the environment remains unstable, we enter the second half of the year with confidence that 2026 will be another year of delivery, aligned with our value creation model and mid-term ambitions,” he added.
Danone’s €1bn bid for Huel faces CMA scrutiny in the UK.
